Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

14 projects found matching your search criteria :

  1. Heterogeneity immunocompetent cells during chimeric antigen receptor T cell (CAR-T) CD19 immunotherapy.

    Call: PRELUDIUM 22 , Panel: NZ6

    Principal investigator: Aleksandra Maria Oszer

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  2. Multiparameter analysis of co-inhibitory and co-stimulatory immune checkpoints and their role in the induction of immuno...

    Call: PRELUDIUM 22 , Panel: NZ6

    Principal investigator: dr Dorota Suszczyk

    Uniwersytet Medyczny w Lublinie

  3. New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Anna Wardowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  4. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Call: OPUS 22 , Panel: NZ6

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii PAN

  5. The clinical significance of immunosuppression in ovarian cancer microenvironments

    Call: PRELUDIUM 20 , Panel: NZ6

    Principal investigator: dr Anna Maria Pawłowska-Łachut

    Uniwersytet Medyczny w Lublinie

  6. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński, Wydział Chemii

  7. Development of a three-dimensional in vitro model for studying the mechanisms of immunostimulatory activity of PD-1/PD-L...

    Call: PRELUDIUM 18 , Panel: NZ5

    Principal investigator: Justyna Natalia Kocik-Król

    Uniwersytet Jagielloński, Wydział Chemii

  8. The immune checkpoints in non-small cell lung cancer - research on genetic and epigenetic mechanism regulating mRNA and ...

    Call: OPUS 17 , Panel: NZ5

    Principal investigator: dr hab. Monika Jasek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  9. Inhibitors of BTLA-HVEM complex formation as potential targets for cancer immunotheraphy

    Call: SONATA 13 , Panel: ST5

    Principal investigator: dr Marta Marcelina Spodzieja

    Uniwersytet Gdański, Wydział Chemii

  10. Structural and functional analysis of immune checkpoints

    Call: OPUS 13 , Panel: NZ1

    Principal investigator: prof. Grzegorz Dubin

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  11. Guardian of a cell cycle: role of HO-1 in HSC proliferation

    Call: PRELUDIUM 13 , Panel: NZ1

    Principal investigator: Monika Żukowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  12. Genotoxicity of antitumor compound 3-bromopyruvate in the yeast Saccharomyces cerevisiae.

    Call: SONATA 9 , Panel: NZ2

    Principal investigator: dr Magdalena Cal

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

  13. MAP kinase signaling pathway in response to replication stress and DNA damage in root meristem cells of Vicia faba

    Call: PRELUDIUM 1 , Panel: NZ3

    Principal investigator: Konrad Szczepan Winnicki

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska; Katedra Cytofizjologii

  14. Genotoxicity of arsenic in the yeast Saccharomyces cerevisiae

    Call: PRELUDIUM 1 , Panel: NZ2

    Principal investigator: dr Ireneusz Bernard Litwin

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych